Skip to content
Search

Latest Stories

Pharmacy employers must notify HSE if staff pick Covid-19 infections at work: PDA

Pharmacy staff and locums are reminded to inform their employers in writing if they believe they are likely to have contracted Covid-19 while at work.

The Pharmacists’ Defence Association (PDA) is concerned that some employers appear unwilling to comply with their logal duty to report such infections to Health & Safety Executive (HSE).


In a statement issued on Wednessday (May 6), the PDA said: "We are advising all members who believe they are likely to have contracted COVID-19 in the workplace to notify their employer in writing of this, and request a copy of the HSE report.”

It added that employers have legal responsibilities for maintaining the health and safety of their staff members at workplace and this includes reporting incidents to the relevant authority.

Following recent announcement that pharmacists would be eligible for the government's COVID-19 death-in-service compensation payments, the PDA has advised pharmacists that reporting work acquired COVID-19 infections to the HSE would be an important component in any subsequent claim put to the government scheme on behalf of the deceased.

It noted that any death that occurs as a result of COVID-19 contracted at work must be reported as a workplace fatality within 10 days of the incident.

The PDA has higlighted the following as reasonable evidence of a work acquired coronavirus infection:

  • A pharmacist or pharmacy team member subsequently contracts Covid-19 after working in proximity to a colleague who has a coronavirus infection, particularly if social distancing cannot be observed in the pharmacy and PPE is not being used appropriately, or at all.
  • A pharmacist or pharmacy team member contracts Covid-19 after encountering a member of the public at work who has a coronavirus infection, whether this was known at the time of the encounter or not.
  • A pharmacist or pharmacy team member contracts Covid-19 from a colleague or patient after working in a hospital pharmacy department where social distancing is not possible and PPE is prioritised for other clinical areas due to supply shortages.

According to the PDA, only reasonable evidence of catching it at work is required to reach the reporting threshold, rather than conclusive proof to prove the infection.

More For You

The Complete Anti-Inflammatory Guide - a useful resource for pharmacists to support patient health and wellbeing

Chronic inflammation is linked to more than 50 per cent of all deaths worldwide and one in five cancers.

The Complete Anti-Inflammatory Guide - a useful resource for pharmacists to support patient health and wellbeing

When Hemant Patel was struck down by Covid, he was determined to discover what was it that led to the disease having a devastating impact on the lives of people who seemed be healthy – the culmination of his journey is the book, The Complete Anti-Inflammatory Guide.

“I was gasping for breath and counting the number of days I might be alive when I was infected with Covid,” reveals Patel.

Keep ReadingShow less
Scottish community pharmacist working in high street pharmacy with supportive environment

The PDA wants investment to reach those who deliver services to patients every day

Pic credit: iStock

Funding boost in Scotland “needs to work for not just pharmacy owners but pharmacists too”, says PDA

An increase in funding for community pharmacies in Scotland needs to lead to a greater focus on supporting pharmacists rather than “simply sustain business models”, according to the Pharmacy Defence Association (PDA).

Earlier this week, Community Pharmacy Scotland (CPS) accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

Keep ReadingShow less
GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less
Paul Bennett
Paul Bennett, CEO, Royal Pharmaceutical Society
Paul Bennett, CEO, Royal Pharmaceutical Society

Pharmacists need to take advantage of independent prescribing pathways, says Bennett

Independent prescribing will be a “significant point” in the history of community pharmacy, according to Royal Pharmaceutical Society chief executive Paul Bennett.

Last month, the RPS announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

Keep ReadingShow less